Previous studies indicated that KCNQ2 missense variants were associated with severe epilepsy phenotype and poor neurological outcomes because of dominant-negative effects (Orhan et al., 2014), whereas truncating variants were likely to be KCNQ2-BFNE (Soldovieri et al., 2007). Here, KCNQ2 is linked to epilepsy.